Balancing benefits and risks in lung cancer therapies: patient preferences for lung cancer treatment alternatives

Balancing benefits and risks in lung cancer therapies: patient preferences for lung cancer treatment alternatives

BackgroundIn the treatment of Non-Small Cell Lung Cancer (NSCLC) the combination of Immuno- Oncotherapy (IO) and chemotherapy (CT) has been found to be superior to IO or CT alone for patients’ survival. Patients and clinicians are confronted with a preference sensitive choice between a more aggressi...

Full description

Bibliographic Details
Main Authors: Serena Oliveri, Lucilla Lanzoni, Jorien Veldwijk, G. Ardine de Wit, Serena Petrocchi, Rosanne Janssens, Elise Schoefs, Meredith Y. Smith, Ian Smith, Kristiaan Nackaerts, Marie Vandevelde, Evelyne Louis, Herbert Decaluwé, Paul De Leyn, Hanne Declerck, Francesco Petrella, Monica Casiraghi, Giulia Galli, Marina Chiara Garassino, Charis Girvalaki, Isabelle Huys, Gabriella Pravettoni
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Psychology
Subjects:
non-small cell lung cancer
patient preference
discrete-choice experiment
mixed logit model
maximum acceptable risk
minimum acceptable benefit
Online Access:https://www.frontiersin.org/articles/10.3389/fpsyg.2023.1062830/full

Internet

https://www.frontiersin.org/articles/10.3389/fpsyg.2023.1062830/full

Similar Items